New Hope Corporation: Cash harvest season

About the author:

Tom Sartor
Author name:
By Tom Sartor
Job title:
Senior Analyst
Date posted:
22 September 2021, 9:00 AM
Sectors Covered:
Junior (Emerging) Resources, Bulk Materials

  • Abnormals linked to Acland’s ramp-down took some shine off NHC’s otherwise strong FY21 operating results.
  • Stronger than expected coal pricing again drives upgrades, with tight physical market dynamics suggesting ongoing upside risk to our coal price deck.
  • Base case valuation adjusts to (login to view). Bull case valuation is (login to view).
  • We see clear upside to both capital and shareholder returns for NHC, particularly if no M&A/ major investment is executed in the near term.

FY21 result snapshot

Revenue ($1048m) and underlying EBITDA ($367m) were within 1-4% of our forecasts. Op cashflow ($296m) was ~$60m below as we underestimated abnormals linked to Acland’s ramp-down re unused rail capacity ($37m), redundancies/super ($25m), liquidation, growth and M&A expenses, and higher receivables.

Final dividend of 7cps was conservatively below consensus (9cps).

Key takeaways / analysis

Price realisations through FY21 have surprised us to the upside. Washing harder to a lower-ash spec is clearly highly accretive and we infer the marketing strategy is more assertive around spot sales and FX.

NHC’s strategy remains consistent (strong BS, dividend stream, M&A optionality not limited to coal/Aus) but no quantitative guidance was offered. We model higher Bengalla volume in FY22 (no major shuts) at slightly higher costs recognising industry cost pressure and added pre-strip capacity. 

We forecast Bengalla to generate A$710m of FY22 EBITDA at cash margins of ~A$90/t or 61%. Risks look skewed to the upside linked to higher index prices above our forecasts and lower sales into JPU pricing. Our forecasts imply a FY22 yield of 11%, but on a higher payout than cited by NHC (~25% of EBITDA), although we do note NHC will charge into a net cash position during 1QFY22. 

M&A state of play: We think that the probability of NHC (or anyone else) acquiring Mount Arthur from BHP is now low given lease complexities, its vastly improved profitability and likely abatement in urgency to sell. NHC may pursue other assets, but with Acland 3 still in the background, we think that surplus cashflow will spill-over into higher dividends before NHC’s next major investment unfolds.

Acland 3: The project’s fourth Land Court hearing commences November with recommendations expected in Feb-March. A positive recommendation (then put to the Minister) would be a bonus as we risk the project to zero in our valuation. We value Acland 3 at 43cps on an un-risked basis.

Forecast and valuation update

~40-90% upgrades to FY22-23 EBITDA based on rolling coal price upgrades.

DCF based valuation revises to (login to view) conservatively built predominantly on Bengalla’s cash flows only. Our valuation under a bullish pricing scenario comparable in duration to the 2017-18 period is (login to view).

Investment view

NHC offers ~23% upside to our base case valuation, with upside linked to persistently higher coal prices above our conservative forecasts. 

NHC retains dry powder for acquisitions, where the ability to move quickly/cleanly is an advantage, but where the obvious sector assets (BMC/ Mt Arthur) are looking less likely to transact in the near term.

Upcoming catalysts

Persistently higher coal prices above our forecasts, potential M&A, Acland 3 Land Court process (due Mar-Q 22).


Potential M&A does bring risk as well as opportunities depending on funding, structure, value and the motivations of key counterparties.

Production disruption from a single key asset, commodity price and FX volatility

Find out more

Download full research note

If you would like access or more information, please contact your adviser or nearest Morgans office.

Request a call  Find local branch

Need access to our research?

You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team

Create trial account 

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

  • Print this page
  • Copy Link